Table 7.
Duration of hospitalization and SARS-CoV-2 negativity in different groups
Variables | Mean ± SD | p-values (one-tail) | p-values (two-tails) |
---|---|---|---|
Clinical outcomes mild COVID-19 patients for SOC and SOC ± Euphorbia neriifoliatreatment | |||
Duration of hospital stay-day for mild COVID-19 patients for SOC treatment (control) | 17.333 ± 3.416 (17; 10–36) |
0.0000** | 0.0000** |
Duration of hospital stay-day for mild COVID-19 patients for SOC ± E. neriifolia treatment | 4.200 ± 1.014 (4; 2–8) |
||
Clinical outcomes moderate COVID-19 patients for SOC and SOC ± Euphorbia neriifoliatreatment | |||
Duration of hospital stay-day for moderate COVID-19 patients for SOC treatment (control) | 29.400 ± 8.365 (30; 12–45) |
0.0000** | 0.0000** |
Duration of hospital stay-day for moderate COVID-19 patients for SOC ± E. neriifolia treatment | 8.467 ± 3.739 (7; 4–12) |
Data are shown as mean ± standard deviation. Statistical significance was considered when p-value was <0.01 and <0.05 and shown as ** and * mark, respectively. p value calculated with 5% level of significance